Tryptophan increases brain 5HT and produces behavioural effects because tryptophan hydroxylase in brain is not saturated by the amount of tryptophan available physiologically.
DRUGS AFFECTING 5HT SYSTEM
Tryptophan increases
brain 5HT and produces behavioural effects because tryptophan hydroxylase
in brain is not saturated by the amount of tryptophan available
physiologically.
p-Chlorophenylalanine
(PCPA) selectively inhibits tryptophan hydroxylase (rate limiting step)
and reduces 5HT level in tissues. It is not used clinically due to high
toxicity.
Tricyclic
antidepressants inhibit 5HT uptake along with that of NA. Some like
fluoxetine, sertraline are selective serotonin reuptake inhibitors (SSRI).
Reserpine
blocks 5HT (as well as NA) uptake into storage granules and causes
depletion of all monoamines. Fenfluramine selectively releases 5HT and has anorectic
property.
Nonselective MAO
inhibitor (tranylcypromine) and selective MAOA inhibitor (chlorgyline)
increase 5HT content by preventing its degradation.
5,
6 dihydroxytryptamine selectively destroys 5HT neurones.
7.
5HT Receptor Agonists
A
diverse range of compounds producing a variety of actions have been found to
activate one or more subtypes of 5HT receptors. Notable among these are:
a.
D-Lysergic acid
diethyl amide (LSD)—Synthesized as an ergot derivative LSD was found to be an extremely potent
hallucinogen. It is a nonselective 5HT agonist— activates many subtypes of 5HT
receptors including 5HT1A on raphe cell bodies, 5HT2A/2C
(probably responsible for the hallucinogenic effect) and 5HT57 in
specific brain areas. However, it antagonizes 5HT2A receptors in the
ileum. A number of other hallucinogens also interact with brain 5HT receptors.
b.
Azapirones like buspirone, gepirone and ipsapirone are a new class of antianxiety drugs which
do not produce sedation. They act as partial agonists of 5HT1A
receptors in the brain.
c.
8-Hydroxydipropylamino
tetraline (8OH DPAT) is a highly selective 5HT1A
agonist which is used only as an experimental tool.
d.
Sumatriptan and other triptans are selective 5HT1B/1D agonists, constrict
cerebral blood vessels and have emerged as the most effective treatment of
acute migraine attacks.
e.
Cisapride This prokinetic drug
which increases gastrointestinal
motility is a selective 5HT4 agonist. Renzapride is still more
selective for 5HT4 receptors.
f.
m-chlorophenyl
piperazine (mCPP) It is an active metabolite of the antidepressant drug
trazodone; found to be an agonist of 5HT1B as well as 5HT2A/2C
receptors in the brain. In human volunteers it induces anxiety and enhances
release of prolactin, ACTH, and growth hormone.
A
variety of drugs block serotonergic receptors; many are nonselective,
but some newer ones are highly subtype selective.
Related Topics
TH 2019 - 2025 pharmacy180.com; Developed by Therithal info.